Ypsomed Hldg
Price
Price
CHART BY
Historical dividends and forecast
Ypsomed Hldg has so far distributed $3.325 in 2024. The next dividend will be paid on 02.07.2025
CHART BY
Frequently asked questions
What is Ypsomed Hldg's market capitalization?
What is Ypsomed Hldg's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for Ypsomed Hldg?
What are the analyst ratings and target price for Ypsomed Hldg's stock?
What is Ypsomed Hldg's revenue over the trailing twelve months?
What is the EBITDA for Ypsomed Hldg?
What is the free cash flow of Ypsomed Hldg?
How many employees does Ypsomed Hldg have, and what sector and industry does it belong to?
What is the free float of Ypsomed Hldg's shares?
Financials
- Market Cap
- 4.45B
- EPS (TTM)
- $5.454
- Free Float
- 3.63M
- P/E ratio (TTM)
- 59.87
- Revenue (TTM)
- 617.07M
- EBITDA (TTM)
- 178.76M
- Free Cashflow (TTM)
- -8.12M
Pricing
- 1D span
- $363.16$373.92
- 52W span
- $290.39$517.72
Analyst Ratings
The price target is 427.57 and the stock is covered by 8 analysts.
Buy
4
Hold
3
Sell
1
Information
Ypsomed Holding AG engages in the development and manufacture of injection systems for self-medication of drugs by patients, most notably used to treat diabetes. It operates through the following segments: Ypsomed Diabetes Care, Ypsomed Delivery Systems, and Others. The Ypsomed Diabetes Care segment is involved in the products that are sold directly to hospitals, doctors, pharmacies, and patients via Ypsomed subsidiaries and distributors. The Ypsomed Delivery Systems segment focuses on the pharmaceutical and biotech customers with injection systems and related services. The Others segment consists of Ypsotec and properties not used for operational purposes. The company was founded by Wilhelm Michel on December 29, 2003, and is headquartered in Burgdorf, Switzerland.
- Employees
- 2,296
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- ISIN
- CH0019396990
- Primary Ticker
- YPSN